StepStone Group Portfolio holdings
StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$7.3M |
| 2 |
Alphatec Holdings
ATEC
|
+$191K |
| 3 |
Hallador Energy
HNRG
|
+$22K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 100% |
| 2 | Healthcare | 0% |
| 3 | Utilities | 0% |
Similar funds
StepStone Group's Q3 2019 Portfolio in Review
As of Q3 2019, StepStone Group held 4 positions worth $57.2M, down 13% from $66.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
StepStone Group withdrew a net $7.52M in Q3 2019, closing 3 positions. Its most notable exit was NovoCure, an estimated $7.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 100% of assets, up from 89% a quarter earlier, followed by Healthcare and Utilities.
- StepStone Group fully exited NovoCure in Q3 2019, selling an estimated $7.3M.
- StepStone Group's ten largest holdings make up 100% of its $57.2M portfolio in Q3 2019.
- StepStone Group opened 0 new positions and closed 3 in Q3 2019.
- StepStone Group's portfolio value fell 13% quarter-over-quarter to $57.2M.
Based on StepStone Group's 13F filing for Q3 2019, filed 12 Nov 2019.